Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Lung Non-Small Cell Carcinoma”

230 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 230 results

Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT01976741
What this trial is testing

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Who this might be right for
Neoplasms
Bayer 168
Not applicableStudy completedNCT02623257
What this trial is testing

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic
First People's Hospital of Hangzhou 1,055
Early research (Phase 1)Not Yet RecruitingNCT07351565
What this trial is testing

Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Chang Chen 22
Early research (Phase 1)Active Not RecruitingNCT02998567
What this trial is testing

Combination Study of Guadecitabine/ASTX727 and Pembrolizumab

Who this might be right for
Non Small Cell Lung Cancer
Royal Marsden NHS Foundation Trust 60
Early research (Phase 1)Study completedNCT01134016
What this trial is testing

Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects

Who this might be right for
Non-small Cell Lung Cancer
Golden Biotechnology Corporation 13
Testing effectiveness (Phase 2)Study completedNCT02531737
What this trial is testing

Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer

Who this might be right for
Lung Neoplasms
University Hospital, Limoges 59
Testing effectiveness (Phase 2)Study completedNCT00064012
What this trial is testing

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Wisconsin, Madison 4
Testing effectiveness (Phase 2)UnknownNCT05265650
What this trial is testing

Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Clinica Universidad de Navarra, Universidad de Navarra 30
Not applicableNo Longer AvailableNCT05225259
What this trial is testing

Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor

Who this might be right for
Carcinoma, Non-Small-Cell LungThyroid Neoplasms
Eli Lilly and Company
Testing effectiveness (Phase 2)Ended earlyNCT02094560
What this trial is testing

CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors

Who this might be right for
Advanced Endstage Solid Carcinomas in Adults
CellAct Pharma GmbH 45
Testing effectiveness (Phase 2)Looking for participantsNCT06538012
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticLung Cancer, Non-small Cell+1 more
Essen Biotech 85
Testing effectiveness (Phase 2)Study completedNCT00024076
What this trial is testing

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+1 more
Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06015724
What this trial is testing

Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaRefractory Non-Small Cell Lung Cancer
Georgetown University 54
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Early research (Phase 1)Ended earlyNCT00569296
What this trial is testing

Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Roger Williams Medical Center 5
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT00674258
What this trial is testing

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Tokyo University 14
Load More Results